Plumbagin modulates leukemia cell redox status

Molecules

Volumn 19, Issue 7, 2014, Pages 10011-10032

  Gaascht, François ^a   Teiten, Marie Hélène ^a   Cerella, Claudia ^a   Dicato, Mario ^a   Bagrel, Denyse ^b   Diederich, Marc ^c  

^a LABORATOIRE DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE DU CANCER   (Luxembourg)

^b UNIVERSITÉ DE LORRAINE   (France)

^c Seoul National University   (South Korea)

Author keywords

Apoptosis; Cancer; Glutathione; Leukemia; Natural products; Plumbagin; Reactive oxygen species; Thiol groups

Indexed keywords

ANTINEOPLASTIC AGENT; ANTIOXIDANT; GLUTATHIONE; NAPHTHOQUINONE; PLUMBAGIN; REACTIVE OXYGEN METABOLITE;

APOPTOSIS; CELL SURVIVAL; DRUG EFFECTS; HUMAN; LEUKEMIA; METABOLISM; OXIDATION REDUCTION REACTION; TUMOR CELL LINE; U937 CELL LINE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTIOXIDANTS; APOPTOSIS; CELL LINE, TUMOR; CELL SURVIVAL; GLUTATHIONE; HUMANS; LEUKEMIA; NAPHTHOQUINONES; OXIDATION-REDUCTION; REACTIVE OXYGEN SPECIES; U937 CELLS;

EID: 84904803075     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules190710011     Document Type: Article

References (68)

1. Florean, C.; Schnekenburger, M.; Grandjenette, C.; Dicato, M.; Diederich, M. Epigenomics of leukemia: From mechanisms to therapeutic applications. Epigenomics 2011, 3, 581-609.
2. Karius, T.; Schnekenburger, M.; Dicato, M.; Diederich, M. Micrornas in cancer management and their modulation by dietary agents. Biochem. Pharmacol. 2012, 83, 1591-1601.
3. Schnekenburger, M.; Diederich, M. Epigenetics offer new horizons for colorectal cancer prevention. Curr. Colorectal Cancer Rep. 2012, 8, 66-81.
4. Gaascht, F.; Teiten, M.H.; Schumacher, M.; Dicato, M.; Diederich, M. Approche végétale dans le traitement des leucémies. Corresp. Onco-Hématol. 2010, V, 102-108.
5. Teiten, M.H.; Gaascht, F.; Dicato, M.; Diederich, M. Anticancer bioactivity of compounds from medicinal plants used in european medieval traditions. Biochem. Pharmacol. 2013, 86, 1239-1247.
6. Sawadogo, W.R.; Schumacher, M.; Teiten, M.H.; Dicato, M.; Diederich, M. Traditional west african pharmacopeia, plants and derived compounds for cancer therapy. Biochem. Pharmacol. 2012, 84, 1225-1240.
7. Sawadogo, W.R.; Schumacher, M.; Teiten, M.H.; Cerella, C.; Dicato, M.; Diederich, M. A survey of marine natural compounds and their derivatives with anti-cancer activity reported in 2011. Molecules 2013, 18, 3641-3673.
8. Teiten, M.H.; Gaascht, F.; Eifes, S.; Dicato, M.; Diederich, M. Chemopreventive potential of curcumin in prostate cancer. Genes Nutr. 2010, 5, 61-74.
9. Teiten, M.H.; Eifes, S.; Reuter, S.; Duvoix, A.; Dicato, M.; Diederich, M. Gene expression profiling related to anti-inflammatory properties of curcumin in K562 leukemia cells. Ann. NY Acad. Sci. 2009, 1171, 391-398.
10. Teiten, M.H.; Eifes, S.; Dicato, M.; Diederich, M. Curcumin- The paradigm of a multi- Target natural compound with applications in cancer prevention and treatment. Toxins 2010, 2, 128-162.
11. Teiten, M.H.; Dicato, M.; Diederich, M. Curcumin as a regulator of epigenetic events. Mol. Nutr. Food Res. 2013, 57, 1619-1629.
12. Kelkel, M.; Cerella, C.; Mack, F.; Schneider, T.; Jacob, C.; Schumacher, M.; Dicato, M.; Diederich, M. ROS-independent JNK activation and multisite phosphorylation of Bcl-2 link diallyl tetrasulfide-induced mitotic arrest to apoptosis. Carcinogenesis 2012, 33, 2162-2171.
13. Czepukojc, B.; Baltes, A.K.; Cerella, C.; Kelkel, M.; Viswanathan, U.M.; Salm, F.; Burkholz, T.; Schneider, C.; Dicato, M.; Montenarh, M.; et al. Synthetic polysulfane derivatives induce cell cycle arrest and apoptotic cell death in human hematopoietic cancer cells. Food Chem. Toxicol. 2014, 64, 249-257.
14. Cerella, C.; Dicato, M.; Jacob, C.; Diederich, M. Chemical properties and mechanisms determining the anti-cancer action of garlic-derived organic sulfur compounds. Anticancer Agents Med. Chem. 2011, 11, 267-271.
15. Busch, C.; Jacob, C.; Anwar, A.; Burkholz, T.; Aicha Ba, L.; Cerella, C.; Diederich, M.; Brandt, W.; Wessjohann, L.; Montenarh, M. Diallylpolysulfides induce growth arrest and apoptosis. Int. J. Oncol. 2010, 36, 743-749.
16. Slingerland, M.; Cerella, C.; Guchelaar, H.J.; Diederich, M.; Gelderblom, H. Cardiac glycosides in cancer therapy: From preclinical investigations towards clinical trials. Invest. New Drugs 2013, 31, 1087-1094.
17. Juncker, T.; Cerella, C.; Teiten, M.H.; Morceau, F.; Schumacher, M.; Ghelfi, J.; Gaascht, F.; Schnekenburger, M.; Henry, E.; Dicato, M.; et al. UNBS1450, a steroid cardiac glycoside inducing apoptotic cell death in human leukemia cells. Biochem. Pharmacol. 2011, 81, 13-23.
18. Cerella, C.; Dicato, M.; Diederich, M. Assembling the puzzle of anti-cancer mechanisms triggered by cardiac glycosides. Mitochondrion 2013, 13, 225-234.
19. Ebrahim, W.; Aly, A.H.; Wray, V.; Mandi, A.; Teiten, M.H.; Gaascht, F.; Orlikova, B.; Kassack, M.U.; Lin, W.; Diederich, M.; et al. Embellicines A and B: Absolute configuration and NF-κB transcriptional inhibitory activity. J. Med. Chem. 2013, 56, 2991-2999.
20. Teiten, M.H.; Mack, F.; Debbab, A.; Aly, A.H.; Dicato, M.; Proksch, P.; Diederich, M. Anticancer effect of altersolanol a, a metabolite produced by the endophytic fungus stemphylium globuliferum, mediated by its pro- Apoptotic and anti-invasive potential via the inhibition of NF-κB activity. Bioorg. Med. Chem. 2013, 21, 3850-3858.
21. Aung, H.H.; Chia, L.S.; Goh, N.K.; Chia, T.F.; Ahmed, A.A.; Pare, P.W.; Mabry, T.J. Phenolic constituents from the leaves of the carnivorous plant nepenthes gracilis. Fitoterapia 2002, 73, 445-447.
22. Inbaraj, J.J.; Chignell, C.F. Cytotoxic action of juglone and plumbagin: A mechanistic study using hacat keratinocytes. Chem. Res. Toxicol. 2004, 17, 55-62.
23. Ahmad, A.; Banerjee, S.; Wang, Z.; Kong, D.; Sarkar, F.H. Plumbagin-induced apoptosis of human breast cancer cells is mediated by inactivation of NF-κB and Bcl-2. J. Cell Biochem. 2008, 105, 1461-1471.
24. Hsu, Y.L.; Cho, C.Y.; Kuo, P.L.; Huang, Y.T.; Lin, C.C. Plumbagin (5-hydroxy-2-methyl-1, 4- naphthoquinone) induces apoptosis and cell cycle arrest in A549 cells through p53 accumulation via c-Jun NH2- Terminal kinase-mediated phosphorylation at serine 15 in vitro and in vivo. J. Pharmacol. Exp. Ther. 2006, 318, 484-494.
25. Manu, K.A.; Shanmugam, M.K.; Rajendran, P.; Li, F.; Ramachandran, L.; Hay, H.S.; Kannaiyan, R.; Swamy, S.N.; Vali, S.; Kapoor, S.; et al. Plumbagin inhibits invasion and migration of breast and gastric cancer cells by downregulating the expression of chemokine receptor CXCR4. Mol. Cancer 2011, 10, 107.
26. Powolny, A.A.; Singh, S.V. Plumbagin-induced apoptosis in human prostate cancer cells is associated with modulation of cellular redox status and generation of reactive oxygen species. Pharm. Res. 2008, 25, 2171-2180.
27. Srinivas, P.; Gopinath, G.; Banerji, A.; Dinakar, A.; Srinivas, G. Plumbagin induces reactive oxygen species, which mediate apoptosis in human cervical cancer cells. Mol. Carcinog. 2004, 40, 201-211.
28. Wang, C.C.; Chiang, Y.M.; Sung, S.C.; Hsu, Y.L.; Chang, J.K.; Kuo, P.L. Plumbagin induces cell cycle arrest and apoptosis through reactive oxygen species/c-Jun N- Terminal kinase pathways in human melanoma A375.S2 cells. Cancer Lett. 2008, 259, 82-98.
29. Gomathinayagam, R.; Sowmyalakshmi, S.; Mardhatillah, F.; Kumar, R.; Akbarsha, M.A.; Damodaran, C. Anticancer mechanism of plumbagin, a natural compound, on non-small cell lung cancer cells. Anticancer Res. 2008, 28, 785-792.
30. Lee, J.H.; Yeon, J.H.; Kim, H.; Roh, W.; Chae, J.; Park, H.O.; Kim, D.M. The natural anticancer agent plumbagin induces potent cytotoxicity in MCF-7 human breast cancer cells by inhibiting a PI-5 kinase for ros generation. PLoS One 2012, 7, e45023.
31. Nazeem, S.; Azmi, A.S.; Hanif, S.; Ahmad, A.; Mohammad, R.M.; Hadi, S.M.; Kumar, K.S. Plumbagin induces cell death through a copper-redox cycle mechanism in human cancer cells. Mutagenesis 2009, 24, 413-418.
32. Sandur, S.K.; Pandey, M.K.; Sung, B.; Aggarwal, B.B. 5-hydroxy-2-methyl- 1, 4-naphthoquinone, a vitamin K3 analogue, suppresses STAT3 activation pathway through induction of protein tyrosine phosphatase, SHP-1: Potential role in chemosensitization. Mol. Cancer Res. 2010, 8, 107-118.
33. Subramaniya, B.R.; Srinivasan, G.; Sadullah, S.S.; Davis, N.; Subhadara, L.B.; Halagowder, D.; Sivasitambaram, N.D. Apoptosis inducing effect of plumbagin on colonic cancer cells depends on expression of COX-2. PLoS One 2011, 6, e18695.
34. Sun, J.; McKallip, R.J. Plumbagin treatment leads to apoptosis in human K562 leukemia cells through increased ROS and elevated TRAIL receptor expression. Leuk. Res. 2011, 35, 1402-1408.
35. Lai, L.; Liu, J.; Zhai, D.; Lin, Q.; He, L.; Dong, Y.; Zhang, J.; Lu, B.; Chen, Y.; Yi, Z.; et al. Plumbagin inhibits tumour angiogenesis and tumour growth through the RAS signalling pathway following activation of the VEGF receptor-2. Br. J. Pharmacol. 2012, 165, 1084-1096.
36. Sinha, S.; Pal, K.; Elkhanany, A.; Dutta, S.; Cao, Y.; Mondal, G.; Iyer, S.; Somasundaram, V.; Couch, F.J.; Shridhar, V.; et al. Plumbagin inhibits tumorigenesis and angiogenesis of ovarian cancer cells in vivo. Int. J. Cancer 2013, 132, 1201-1212.
37. Sandur, S.K.; Ichikawa, H.; Sethi, G.; Ahn, K.S.; Aggarwal, B.B. Plumbagin (5-hydroxy-2- methyl-1, 4-naphthoquinone) suppresses NF-κB activation and NF-κB-regulated gene products through modulation of p65 and ikappabalpha kinase activation, leading to potentiation of apoptosis induced by cytokine and chemotherapeutic agents. J. Biol. Chem. 2006, 281, 17023-17033.
38. Xu, T.P.; Shen, H.; Liu, L.X.; Shu, Y.Q. Plumbagin from plumbago zeylanica l induces apoptosis in human non-small cell lung cancer cell lines through NF-κB inactivation. Asian Pac. J. Cancer Prev. 2013, 14, 2325-2331.
39. Yang, S.J.; Chang, S.C.; Wen, H.C.; Chen, C.Y.; Liao, J.F.; Chang, C.H. Plumbagin activates ERK1/2 and AKT via superoxide, SRC and PI3-kinase in 3T3-l1 cells. Eur. J. Pharmacol. 2010, 638, 21-28.
40. Dhar, S.K.; Tangpong, J.; Chaiswing, L.; Oberley, T.D.; Clair, D.K. Manganese superoxide dismutase is a p53-regulated gene that switches cancers between early and advanced stages. Cancer Res. 2011, 71, 6684-6695.
41. Lincoln, D.T.; Ali Emadi, E.M.; Tonissen, K.F.; Clarke, F.M. The thioredoxin- Thioredoxin reductase system: Over-expression in human cancer. Anticancer Res. 2003, 23, 2425-2433.
42. Perry, R.R.; Mazetta, J.A.; Levin, M.; Barranco, S.C. Glutathione levels and variability in breast tumors and normal tissue. Cancer 1993, 72, 783-787.
43. Skrzycki, M.; Majewska, M.; Podsiad, M.; Czeczot, H. Expression and activity of superoxide dismutase isoenzymes in colorectal cancer. Acta Biochim. Pol. 2009, 56, 663-670.
44. Zhou, J.; Du, Y. Acquisition of resistance of pancreatic cancer cells to 2-methoxyestradiol is associated with the upregulation of manganese superoxide dismutase. Mol. Cancer Res. 2012, 10, 768-777.
45. Checker, R.; Sharma, D.; Sandur, S.K.; Subrahmanyam, G.; Krishnan, S.; Poduval, T.B.; Sainis, K.B. Plumbagin inhibits proliferative and inflammatory responses of T cells independent of ROS generation but by modulating intracellular thiols. J. Cell Biochem. 2010, 110, 1082-1093.
46. Castro, F.A.; Mariani, D.; Panek, A.D.; Eleutherio, E.C.; Pereira, M.D. Cytotoxicity mechanism of two naphthoquinones (menadione and plumbagin) in saccharomyces cerevisiae. PLoS One 2008, 3, e3999.
47. SivaKumar, V.; Prakash, R.; Murali, M.R.; Devaraj, H.; Niranjali Devaraj, S. In vivo micronucleus assay and gst activity in assessing genotoxicity of plumbagin in swiss albino mice. Drug Chem. Toxicol. 2005, 28, 499-507.
48. Srinivasan, L.; Mathew, N.; Muthuswamy, K. In vitro antifilarial activity of glutathione S- Transferase inhibitors. Parasitol. Res. 2009, 105, 1179-1182.
49. Seshadri, P.; Rajaram, A.; Rajaram, R. Plumbagin and juglone induce caspase-3-dependent apoptosis involving the mitochondria through ROS generation in human peripheral blood lymphocytes. Free Radic. Biol. Med. 2011, 51, 2090-2107.
50. Cerella, C.; Sobolewski, C.; Chateauvieux, S.; Henry, E.; Schnekenburger, M.; Ghelfi, J.; Dicato, M.; Diederich, M. Cox-2 inhibitors block chemotherapeutic agent-induced apoptosis prior to commitment in hematopoietic cancer cells. Biochem. Pharmacol. 2011, 82, 1277-1290.
51. Simon, H.U.; Haj-Yehia, A.; Levi-Schaffer, F. Role of reactive oxygen species (ROS) in apoptosis induction. Apoptosis 2000, 5, 415-418.
52. Seo, H.R.; Seo, W.D.; Pyun, B.J.; Lee, B.W.; Jin, Y.B.; Park, K.H.; Seo, E.K.; Lee, Y.J.; Lee, Y.S. Radiosensitization by celastrol is mediated by modification of antioxidant thiol molecules. Chem. Biol. Interact. 2011, 193, 34-42.
53. Monticone, M.; Taherian, R.; Stigliani, S.; Carra, E.; Monteghirfo, S.; Longo, L.; Daga, A.; Dono, M.; Zupo, S.; Giaretti, W.; et al. NAC, tiron and trolox impair survival of cell cultures containing glioblastoma tumorigenic initiating cells by inhibition of cell cycle progression. PLoS One 2014, 9, e90085.
54. Yang, J.; Su, Y.; Richmond, A. Antioxidants tiron and N- Acetyl-l-cysteine differentially mediate apoptosis in melanoma cells via a reactive oxygen species-independent NF-κB pathway. Free Radic. Biol. Med. 2007, 42, 1369-1380.
55. Arrigo, A.P. Gene expression and the thiol redox state. Free Radic. Biol. Med. 1999, 27, 936-944.
56. Huang, Z.Z.; Chen, C.; Zeng, Z.; Yang, H.; Oh, J.; Chen, L.; Lu, S.C. Mechanism and significance of increased glutathione level in human hepatocellular carcinoma and liver regeneration. FASEB J. 2001, 15, 19-21.
57. Warner, B.B.; Stuart, L.; Gebb, S.; Wispe, J.R. Redox regulation of manganese superoxide dismutase. Am. J. Physiol. 1996, 271, L150-L158.
58. Franco, R.; Cidlowski, J.A. Glutathione efflux and cell death. Antioxid. Redox Signaling 2012, 17, 1694-1713.
59. Schumacher, M.; Cerella, C.; Eifes, S.; Chateauvieux, S.; Morceau, F.; Jaspars, M.; Dicato, M.; Diederich, M. Heteronemin, a spongean sesterterpene, inhibits tnf alpha-induced NF-kappa b activation through proteasome inhibition and induces apoptotic cell death. Biochem. Pharmacol. 2010, 79, 610-622.
60. D'Alessio, M.; Cerella, C.; Amici, C.; Pesce, C.; Coppola, S.; Fanelli, C.; de Nicola, M.; Cristofanon, S.; Clavarino, G.; Bergamaschi, A.; et al. Glutathione depletion up-regulates BCL-2 in BSO-resistant cells. FASEB J. 2004, 18, 1609-1611.
61. Acharya, B.R.; Bhattacharyya, B.; Chakrabarti, G. The natural naphthoquinone plumbagin exhibits antiproliferative activity and disrupts the microtubule network through tubulin binding. Biochemistry 2008, 47, 7838-7845.
62. Ghibelli, L.; Diederich, M. Multistep and multitask bax activation. Mitochondrion 2010, 10, 604-613.
63. 2-induced apoptosis. J. Biol. Chem. 2008, 283, 15359-15369.
64. Honda, T.; Coppola, S.; Ghibelli, L.; Cho, S.H.; Kagawa, S.; Spurgers, K.B.; Brisbay, S.M.; Roth, J.A.; Meyn, R.E.; Fang, B.; et al. GSH depletion enhances adenoviral bax-induced apoptosis in lung cancer cells. Cancer Gene Ther. 2004, 11, 249-255.
65. D'Alessio, M.; de Nicola, M.; Coppola, S.; Gualandi, G.; Pugliese, L.; Cerella, C.; Cristofanon, S.; Civitareale, P.; Ciriolo, M.R.; Bergamaschi, A.; et al. Oxidative Bax dimerization promotes its translocation to mitochondria independently of apoptosis. FASEB J. 2005, 19, 1504-1506.
66. Turella, P.; Cerella, C.; Filomeni, G.; Bullo, A.; de Maria, F.; Ghibelli, L.; Ciriolo, M.R.; Cianfriglia, M.; Mattei, M.; Federici, G.; et al. Proapoptotic activity of new glutathione S- Transferase inhibitors. Cancer Res. 2005, 65, 3751-3761.
67. Duvoix, A.; Schnekenburger, M.; Delhalle, S.; Blasius, R.; Borde-Chiche, P.; Morceau, F.; Dicato, M.; Diederich, M. Expression of glutathione S- Transferase P1-1 in leukemic cells is regulated by inducible AP-1 binding. Cancer Lett. 2004, 216, 207-219.
68. Karius, T.; Schnekenburger, M.; Ghelfi, J.; Walter, J.; Dicato, M.; Diederich, M. Reversible epigenetic fingerprint-mediated glutathione-s- Transferase P1 gene silencing in human leukemia cell lines. Biochem. Pharmacol. 2011, 81, 1329-1342.